National Amyloidosis Center Model (ATTRwt and ATTRv):
Survival Probabilities by Disease Stage1

Staging of cardiac ATTR amyloidosis at diagnosis using NT-proBNP and eGFR
Survival Probability
1.00
0.75
0.50
0.25
0.00
Follow Up (Months)
0
20
40
60
Number at risk
Stage I 393 254 117 58
Stage II 334 181 78 30
Stage III 142 60 15 8
Stage Median Survival
(months)
Hazard Ratio For
Death (95% CI)
1 69.2 Reference
2 46.7 2.05 (1.5-2.8)
3 24.1 3.8 (2.7-5.3)
Stage I

Stage II

Stage III